-+ 0.00%
-+ 0.00%
-+ 0.00%

Rosenblatt Maintains Buy on Imax, Raises Price Target to $60

Benzinga·08/10/2026 11:48:08
Listen to the news
Rosenblatt analyst Steve Frankel maintains Imax (NYSE:IMAX) with a Buy and raises the price target from $50 to $60.